AstraZeneca picks up abandoned DSM facility
Just weeks after announcing intentions to snap up biologics firm MedImmune, AstraZeneca has acquired DSM's old biologics manufacturing facility in Montreal, Canada, a site that's been gathering dust since it was mothballed by the firm last year.